Drug intelligence / Profile preview

evernic acid

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Evernic acid is a natural depside and secondary metabolite primarily isolated from lichen species such as *Evernia prunastri* (oakmoss). It is being extensively researched for its potential as an adjuvant in oncology, where it has demonstrated the ability to enhance the sensitivity of cancer cells to traditional chemotherapeutic agents like temozolomide and paclitaxel. Its mechanism of action involves the modulation of the Wnt signaling pathway and the exertion of immunomodulatory effects, which help overcome drug resistance in glioblastoma and breast cancer models. Additionally, evernic acid exhibits significant anti-inflammatory and antioxidant properties, leading to investigations into its neuroprotective potential, particularly in mitigating neuroinflammation and dopaminergic neuronal loss in models of Parkinson's disease.

Other names
2-hydroxy-4-[(2-hydroxy-4-methoxy-6-methylbenzoyl)oxy]-6-methylbenzoic acid
02

Targets

FZD7 (Frizzled class receptor 7)WIF1 (Wnt inhibitory factor 1)

Beyond the preview

Go deeper on evernic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on evernic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call